(Q35617980)

9 August 2017

0 references

Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis (English)

1 reference

9 August 2017

acute myeloid leukemia

1 reference

1 reference

Shuangnian Xu

1

1 reference

9 August 2017

Xi Li

series ordinal

2

1 reference

9 August 2017

Jianmin Zhang

series ordinal

3

1 reference

9 August 2017

Jieping Chen

series ordinal

4

1 reference

9 August 2017

30 April 2015

1 reference

Journal of Cancer Research and Clinical Oncology

9 August 2017

1 reference

9 August 2017

141

1 reference

9 August 2017

10

1 reference

9 August 2017

1859-1870

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-015-1977-3

9 August 2017

0 references

cites work

The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Acute myeloid leukaemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Clinical and biological significance of CD56 antigen expression in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Molecular cytogenetics and multiplex reverse-transcriptase polymerase chain reaction for risk stratification in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-015-1977-3

Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

12 December 2020

JAMA patient page. Acute myeloid leukemia

1 reference

12 December 2020

Prognostic significance of CD56 antigen expression in acute myeloid leukemia

1 reference

12 December 2020

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.

1 reference

12 December 2020

[Expression of CD56 in acute leukemia and its clinical significance]

1 reference

12 December 2020

Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis

1 reference

12 December 2020

Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).

1 reference

12 December 2020

CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

1 reference

12 December 2020

High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan

1 reference

12 December 2020

Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype

1 reference

12 December 2020

CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy

1 reference

12 December 2020

[Clinical characteristics of CD56(+) patients with acute monocytic leukemia and their prognostic significance]

1 reference

12 December 2020

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

10.1007/S00432-015-1977-3

Identifiers

DOI

1 reference

9 August 2017

1 reference